M. Egorin

Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors (2003)

Goel, S., Bulgaru, A., Hochster, H., Wadler, S., Zamboni, W., Egorin, M., ...

Background: The aim of this study was to determine the maximum tolerated dose, recommended phase II dose (RPTD) and toxicities of the FOG regimen (infusional 5-fluorouracil, oxaliplatin,...

A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer (2001)

Olver, I. N., Davy, M., Luftner, D., Park, S-H., Egorin, M., Ellis, A., ...

A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer (2001)

Olver, I. N., Davy, M., Luftner, D., Park, S-H., Egorin, M., Ellis, A., ...